Publications by authors named "Ahmed Salleh Barefah"

The occurrence of oral squamous cell carcinoma synchronously with lymphoma arising primarily in cervical lymph nodes is rare. Here, we report a case representing an infrequent finding. A 66-year-old male who was diagnosed with right mandibular squamous cell carcinoma and was subsequently found to have a nodal follicular lymphoma as a second malignancy.

View Article and Find Full Text PDF

Background: -thalassemia is an inherited blood disorder that affects the production of hemoglobin molecules owing to the reduction or absence of beta chains. Transfusion therapy has had a key role in extending the lifespan of -thalassemia patients. This life-saving therapy is linked to numerous assessments and complications that now comprise most thalassemia management considerations.

View Article and Find Full Text PDF

Background: Tumor protein 53 () is a tumor-suppressor gene and plays an essential role in apoptosis, cell cycle arrest, genomic stability, and DNA repair. Although it is the most often mutated gene in human cancer, it has respectively low frequency in hematological malignancy but is significantly linked with complex karyotype, poor prognosis, and chemotherapeutic response. Nevertheless, the prevalence and prognostic role of mutations in hematological malignancy in Saudi patients are not well reported.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ahmed Salleh Barefah"

  • - Ahmed Salleh Barefah's recent research encompasses the intersection of oncology and hematology, with a focus on rare cases of malignancies, as evidenced by a case report on synchronous oral squamous cell carcinoma and follicular lymphoma.
  • - His work also delves into innovative management solutions for chronic conditions, such as developing a smart chatbot aimed at enhancing patient care for individuals with beta-thalassemia, emphasizing the importance of transfusion therapy management.
  • - Additionally, Barefah examines the genetic aspects of hematological malignancies, particularly the role of tumor protein p53 mutations in Saudi patients, shedding light on their prognostic implications and the need for more extensive reporting on this topic.